195 related articles for article (PubMed ID: 28188876)
21. Chitosan-based nanoparticles as delivery systems of therapeutic proteins.
Fonte P; Andrade JC; Seabra V; Sarmento B
Methods Mol Biol; 2012; 899():471-87. PubMed ID: 22735970
[TBL] [Abstract][Full Text] [Related]
22. Controlled release and intracellular protein delivery from mesoporous silica nanoparticles.
Deodhar GV; Adams ML; Trewyn BG
Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27973750
[TBL] [Abstract][Full Text] [Related]
23. Protein-coated nanoparticles embedded in films as delivery platforms.
Morales JO; Ross AC; McConville JT
J Pharm Pharmacol; 2013 Jun; 65(6):827-38. PubMed ID: 23647676
[TBL] [Abstract][Full Text] [Related]
24. Formulation aspects of nanopharmaceuticals and nanotechnology I Introduction, biopharmaceutical aspects.
Viktor F; Emese B; Geza J; Istvan A
Acta Pharm Hung; 2016; 86(2):43-52. PubMed ID: 29873962
[TBL] [Abstract][Full Text] [Related]
25. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
26. The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.
Shahbazi MA; Hamidi M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1774-82. PubMed ID: 23136990
[TBL] [Abstract][Full Text] [Related]
27. Polymeric protective agents for nanoparticles in drug delivery and targeting.
Mogoşanu GD; Grumezescu AM; Bejenaru C; Bejenaru LE
Int J Pharm; 2016 Aug; 510(2):419-29. PubMed ID: 26972379
[TBL] [Abstract][Full Text] [Related]
28. Carboxymethyl chitosan-soy protein complex nanoparticles for the encapsulation and controlled release of vitamin D₃.
Teng Z; Luo Y; Wang Q
Food Chem; 2013 Nov; 141(1):524-32. PubMed ID: 23768389
[TBL] [Abstract][Full Text] [Related]
29. Drug carriers in osteoporosis: preparation, drug encapsulation and applications.
Miladi K; Sfar S; Fessi H; Elaissari A
Int J Pharm; 2013 Mar; 445(1-2):181-95. PubMed ID: 23376227
[TBL] [Abstract][Full Text] [Related]
30. Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery.
Fonte P; Reis S; Sarmento B
J Control Release; 2016 Mar; 225():75-86. PubMed ID: 26805517
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable polymeric nanoparticles based drug delivery systems.
Kumari A; Yadav SK; Yadav SC
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):1-18. PubMed ID: 19782542
[TBL] [Abstract][Full Text] [Related]
32. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
33. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers.
Grabnar PA; Kristl J
J Microencapsul; 2011; 28(4):323-35. PubMed ID: 21545323
[TBL] [Abstract][Full Text] [Related]
34. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
Subia B; Kundu SC
Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
[TBL] [Abstract][Full Text] [Related]
35. Poly(vinyl benzoate) nanoparticles for molecular delivery: Studies on their preparation and in vitro properties.
Labruère R; Sicard R; Cormier R; Turos E; West L
J Control Release; 2010 Dec; 148(2):234-40. PubMed ID: 20728487
[TBL] [Abstract][Full Text] [Related]
36. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
37. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
Elzoghby AO
J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
[TBL] [Abstract][Full Text] [Related]
38. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
[TBL] [Abstract][Full Text] [Related]
39. DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use.
Weissig V
Methods Mol Biol; 2015; 1265():1-11. PubMed ID: 25634263
[TBL] [Abstract][Full Text] [Related]
40. Layer-by-layer nanoparticle platform for cancer active targeting.
Suh MS; Shen J; Kuhn LT; Burgess DJ
Int J Pharm; 2017 Jan; 517(1-2):58-66. PubMed ID: 27923697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
